Apollon Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Apollon Wealth Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$208K	Buy	+4,946	New	+$158K	﹤0.01%	1469
2022 Q1	–	Sell	-3,976	Closed	-$243K	–	765
2021 Q4	$243K	Buy	+3,976	New	+$275K	0.02%	643
2021 Q1	–	Sell	-14,646	Closed	-$1.37M	–	336
2020 Q4	$1.37M	Buy	+14,646	New	+$1.17M	0.37%	63

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Apollon Wealth Management's ARKG Position: Q2 2026 in Review

Apollon Wealth Management opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2026: 4,946 shares worth $208K. The stake represents ﹤0.01% of the portfolio and ranks #1469 among its holdings. This is a return to the name: Apollon Wealth Management previously reported a position in ARKG as recently as Q4 2021.

Apollon Wealth Management first reported a position in ARKG in Q4 2020 and has held it in 3 quarters since. The position peaked at $1.37M in Q4 2020. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Apollon Wealth Management held 4,946 shares of ARK Genomic Revolution ETF worth $208K as of Q2 2026.
ARK Genomic Revolution ETF was a new Apollon Wealth Management position in Q2 2026.
ARK Genomic Revolution ETF made up ﹤0.01% of Apollon Wealth Management's portfolio in Q2 2026, its #1469 holding.
Apollon Wealth Management first reported a position in ARK Genomic Revolution ETF in Q4 2020 and has held it in 3 quarters since.
Apollon Wealth Management's ARK Genomic Revolution ETF position peaked at $1.37M in Q4 2020.
272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.